As of April 16, 2025, CytoMed Therapeutics (GDTC) has a market cap of $27.004 million USD. According to our data, CytoMed Therapeutics is ranked No.8421 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $27.00 M |
-31.18%
|
Dec 31, 2024 | $39.24 M |
-30.61%
|
Dec 29, 2023 | $56.55 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Fate Therapeutics
FATE
|
$0.13 B |
0.000 M
|
![]() USA
|
![]() Adaptimmune Therapeutics
ADAP
|
$64.18 M |
-0.000 M
|
![]() UK
|
![]() Atara Biotherapeutics
ATRA
|
$35.04 M |
-0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.34 B |
0.000 M
|
![]() Switzerland
|
![]() Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.76 B |
-0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$43.76 M |
0.000 M
|
![]() USA
|
![]() Allogene Therapeutics
ALLO
|
$0.32 B |
0.000 M
|
![]() USA
|
![]() Cellectis
CLLS
|
$0.18 B |
36.593 M
|
![]() France
|
![]() Sangamo Therapeutics
SGMO
|
$0.17 B |
0.000 M
|
![]() USA
|
![]() Beam Therapeutics
BEAM
|
$1.73 B |
0.000 M
|
![]() USA
|
![]() Precision BioSciences
DTIL
|
$57.86 M |
0.000 M
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
Market Cap | = | GDTC Stock Price | * | GDTC Shares Outstanding |
= | $2.34 | * | 11.54 M | |
= | $27.00 M |